Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Jacqueline Stella"'
Autor:
Johanna Hetrodt, Christiane Engelbertz, Katrin Gebauer, Jacqueline Stella, Matthias Meyborg, Eva Freisinger, Holger Reinecke, Nasser Malyar
Publikováno v:
Journal of Cardiovascular Development and Disease, Vol 8, Iss 11, p 136 (2021)
Vascular access site complications (ASC) are among the most frequent complications of percutaneous cardiovascular procedures (PCP) and are associated with adverse outcome and high resources utilization. In this prospective study, we investigated pati
Externí odkaz:
https://doaj.org/article/6a852db884c84db5b7ec0d0e7034e39f
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 20; Pages: 6074
Background: Endovascular revascularization (EVR) is a pillar of therapeutic management in patients with symptomatic lower extremity artery disease (LEAD). Due to lack of scientific evidence, the approach of EVR type and the devices used at the differ
Autor:
Katrin Gebauer, Holger Reinecke, Matthias Meyborg, Tim Jakobi, Nasser M. Malyar, Jacqueline Stella, Christiane Engelbertz, Eva Freisinger
Publikováno v:
Journal of Nephrology. 34:811-820
Post-contrast acute kidney injury (AKI) is a dreaded complication of endovascular revascularization using iodinated contrast medium in patients with peripheral artery disease and concomitant chronic kidney disease (CKD). This study sought to evaluate
Autor:
Christoph J Niemietz, Vanessa Sauer, Jacqueline Stella, Lutz Fleischhauer, Gursimran Chandhok, Sarah Guttmann, Yesim Avsar, Shuling Guo, Elizabeth J Ackermann, Jared Gollob, Brett P Monia, Andree Zibert, Hartmut H-J Schmidt
Publikováno v:
PLoS ONE, Vol 11, Iss 9, p e0161455 (2016)
Familial amyloid polyneuropathy (FAP) is caused by mutations of the transthyretin (TTR) gene, predominantly expressed in the liver. Two compounds that knockdown TTR, comprising a small interfering RNA (siRNA; ALN-TTR-02) and an antisense oligonucleot
Externí odkaz:
https://doaj.org/article/1796834c54db428483d9067e5e8d8e11
Autor:
Matthias Meyborg, Holger Reinecke, Eva Freisinger, Kerstin Wintersohl, Rike Kraska, Jacqueline Stella, Christiane Engelbertz, Nasser M. Malyar, Ulrike Fahrland, Katja Kortendick, Katrin Gebauer
Publikováno v:
Herz. 46:280-286
Zusammenfassung Hintergrund Die periphere arterielle Verschlusskrankheit (pAVK) ist eine atherosklerotische Gefäßerkrankung mit hoher Morbidität und Mortalität. Eine konsequente medikamentöse Sekundärprävention gehört zur essenziellen und evi
Autor:
Katrin, Gebauer, Kerstin, Wintersohl, Rike, Kraska, Katja, Kortendick, Ulrike, Fahrland, Eva, Freisinger, Matthias, Meyborg, Jacqueline, Stella, Christiane, Engelbertz, Holger, Reinecke, Nasser, Malyar
Publikováno v:
Herz
Peripheral arterial occlusive disease (PAOD) is an atherosclerotic vascular disease with high morbidity and mortality. A consistent medication-based secondary prevention is part of the essential and evidence-based treatment of PAOD. The aim of this s
Autor:
Juan Hassu, Nasser M. Malyar, Eva Freisinger, Jacqueline Stella, Matthias Meyborg, Katrin Gebauer, Christiane Engelbertz
Publikováno v:
VASA. Zeitschrift fur Gefasskrankheiten. 49(2)
Summary: Background: Patients with chronic critical limb-threatening ischemia (CLTI) are at high risk of amputation and death. Despite the general recommendation for revascularization in CTLI in the guidelines, the underlying evidence for such a reco
Autor:
Christiane Engelbertz, Matthias Meyborg, Jacqueline Stella, Nasser M. Malyar, Eva Freisinger, Katrin Gebauer, Johanna Hetrodt, Holger Reinecke
Publikováno v:
Journal of Cardiovascular Development and Disease
Volume 8
Issue 11
Journal of Cardiovascular Development and Disease, Vol 8, Iss 136, p 136 (2021)
Volume 8
Issue 11
Journal of Cardiovascular Development and Disease, Vol 8, Iss 136, p 136 (2021)
Vascular access site complications (ASC) are among the most frequent complications of percutaneous cardiovascular procedures (PCP) and are associated with adverse outcome and high resources utilization. In this prospective study, we investigated pati
Autor:
Koen van de Wetering, Insa Buers, Yvonne Nitschke, Frank Rutsch, Wolfgang Höhne, Jacqueline Stella
Publikováno v:
Human Mutation. 37:1190-1201
Ectonucleotide pyrophosphatase/phosphodiesterase family member 1 (E-NPP1), encoded by ENPP1, is a plasma membrane protein that generates inorganic pyrophosphate (PPi ), a physiologic inhibitor of hydroxyapatite formation. In humans, variants in ENPP1
Autor:
Justin H Davies, Geneviève Baujat, Samuel J. Garber, Stephen G. Kahler, Olivier Roche, Smail Hadj-Rabia, Jacqueline Stella, Martine Le Merrer, Rashmi Chikarmane, Karen J. Loechner, Wendy E. Smith, Loreto Martorell, Tatevik Shahinyan, Marie-Frederique Tazarourte-Pinturier, Robert Terkeltaub, Elizabeth Wraige, Tanja Wittkampf, Charu Deshpande, Wolfgang Höhne, Lourdes Loidi, Yvonne Nitschke, Ilse Feenstra, Frank Rutsch, Beat Steinmann, Ludovic Martin, Ulrike Botschen, Guest G, K Lambot, Nicolas Chassaing, Marcel du Moulin, Mignon McCulloch
Publikováno v:
American Journal of Human Genetics, 90, 25-39
American Journal of Human Genetics, 90, 1, pp. 25-39
American Journal of Human Genetics, 90, 1, pp. 25-39
Item does not contain fulltext Spontaneous pathologic arterial calcifications in childhood can occur in generalized arterial calcification of infancy (GACI) or in pseudoxanthoma elasticum (PXE). GACI is associated with biallelic mutations in ENPP1 in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::106f9b29f5ee28f1acadd2e4fd42cd8a
https://doi.org/10.5167/uzh-73740
https://doi.org/10.5167/uzh-73740